NEW YORK, July 7 (GenomeWeb News) - MWG Biotech and Artus today announced a co-marketing agreement to distribute ExpressArt, an mRNA amplification kit for all platforms used microarray analysis.
Financial details of the agreement were not disclosed. The product will be available from MWG in September, the company said in a statement. MWG will also offer the product as part of its hybridization services business, but limiting samples accepted to a minimum of 100 nanograms of total RNA.
MWG, and Artus will also continue to collaborate to develop an automated mRNA amplification kit for use on Theonyx, MWG's lab automation platform for microarray experimentation.